Skip to content
Menu

Fresenius Medical Care AG FMS

Full chart Compare
Set alert

Price alert · FMS

All alert types
20.13 USD -0.82 (-3.91%)

Regular-session close

20.12 -0.01 -0.05%

After hours · Nov 19, 4:06 PM ET

20.00 Day range 20.84
20.00 52-week range 26.42
YTD
-15.49%
1 year
-11.67%

5D -1.10 (-4.96%)

2121.5022ThuFriMonTueWed21.08
Market cap
10.45B
Revenue (ttm)
19.48B
Profit margin
4.22%
EPS (ttm)
1.73
Shares out
519.02M
P/E ratio
11.64
Forward P/E
7.66
Dividend
0.87 (4.16%)
Ex-dividend date
May 22, 2026
YTD return
-15.49%
1-year return
-11.67%
Volume
2.10M
Avg volume
1.15M
Open
20.83
Previous close
20.95
Day's range
20.00 – 20.84
52-week range
20.00 – 26.42
Beta
0.79
Analysts
Hold
Price target
21.55 (+7.1%)
Earnings date
Feb 23, 2027
50-day average
22.23

Key statistics

200-day average
22.89
Enterprise value
21.64B
PEG ratio
0.92
Price / sales
0.54
Price / book
0.73
Payout ratio
50.14%
Revenue growth
1.10%
Free cash flow
1.49B
Total cash
1.10B
Total debt
10.90B
Return on equity
7.84%

Fundamental scorecard

13 of 25 checks passed on FMS’s reported financials

ValueGrowthProfitabilityHealthDividend

13of 25 checks passed

  • Value 5 of 5
  • Growth 2 of 5
  • Profitability 4 of 5
  • Financial health 2 of 5
  • Dividend No data

Statements to Sep 30, 2026.

Financials — quick view

All financials
FMS Revenue — quarterly 4.94B
FMS Net income — quarterly 159.78M
FMS EPS — quarterly 0.305

Earnings

FMS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 23, 2027Dec 30, 20260.54———
Nov 3, 2026Sep 30, 20260.6510.64-0.01-1.69%
Aug 3, 2026Jun 30, 20260.6160.66+0.04+7.14%
May 5, 2026Mar 31, 20260.590.53-0.06-10.17%
Feb 24, 2026Dec 31, 20250.6470.83+0.18+28.28%
Nov 4, 2025Sep 30, 20250.590.64+0.05+8.47%

Upgrades / downgrades

FMS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 9, 2026BarclaysdownEqual-WeightUnderweight
Oct 12, 2026Truist SecuritiesmainHoldHold
Aug 6, 2026BernsteinmainMarket PerformMarket Perform
Sep 2, 2025UBSdownNeutralSell
May 12, 2025Truist SecuritiesmainHoldHold
Jan 6, 2025Truist SecuritiesmainHoldHold

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Sector
Healthcare
Industry
Medical Care Facilities
Country
Germany

News

Your note

Sign in to keep a note on FMS — it syncs with the Stock Master app.

Institution ownership

FMS institution ownership
Holder% heldSharesValueReported
Pzena Investment Management LLC3.12%16,617,575334.59MSep 29, 2026
Morgan Stanley0.83%4,424,99989.10MSep 29, 2026
Dodge & Cox Inc.0.63%3,328,11067.01MSep 29, 2026
Brandes Investment Partners L.P.0.37%1,969,74939.66MSep 29, 2026
Todd Asset Management LLC0.33%1,761,48335.47MSep 29, 2026
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY0.21%1,106,40022.28MSep 29, 2026

Fund ownership

FMS fund ownership
Holder% heldSharesValueReported
VANGUARD WINDSOR FUNDS-Vanguard Windsor Fund1.54%8,204,589165.20MJul 30, 2026
Dodge & Cox Funds-Dodge & Cox Balanced Fund0.72%3,826,91077.05MJun 29, 2026
VANGUARD WHITEHALL FUNDS-Vanguard Selected Value Fund0.48%2,539,43151.13MJul 30, 2026
Liberty All Star Equity Fund0.21%1,125,29222.66MJun 29, 2026
John Hancock Capital Series-Classic Value Fund0.18%981,66519.77MSep 29, 2026
Advisors Series Trust-Pzena U.S. Large Cap Value ETF0.02%88,2241.78MAug 30, 2026